Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unac...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
Pocket
Development of a low cost point of care test for Tuberculosi...
4M€
Cerrado
AU-NANOPROBES FOR TB
Disposable Point of Care DNA kit for Mycobacterium tuberculo...
100K€
Cerrado
mfloDx
Adaptable Multiflow Diagnostic Platform to Genetically Ident...
71K€
Cerrado
ARREST-TB
Accurate Rapid Robust and Economical diagnostic technoliog...
4M€
Cerrado
RAPID UTI
AN IMMUNOASSAY-BASED POINT OF CARE TEST KIT FOR RAPID, INEXP...
75K€
Cerrado
TB PROGNOSIS
A progress of tuberculosis and HIV tuberculosis treatment as...
133K€
Cerrado
Información proyecto TOPO-TB
Duración del proyecto: 6 meses
Fecha Inicio: 2015-09-29
Fecha Fin: 2016-03-31
Líder del proyecto
ZYMONOSTICS APS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.
With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme of
the bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples,
will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resource
adaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detection
at the point of care patient level.